Provista Diagnostics Raises $6.0M

Scottsdale, Arizona-based Provista Diagnostics, a firm developing molecular diagnostics products aimed at predictive testing for cancer, said Tuesdya that it has raised $6.0M in a funding round. The Series A funding came from the firm's existing investors, according to the company. Names of those investors were not disclosed. Provista Diganotisc said it is developing a platform for predictive tests for cancers affecting women, including breast, endometrial and ovarian. More information »